SARS-CoV-2 Nucleoprotein IgG Antibody ELISA Kit |
|||
E4821-100 | Biovision | 96 assays | EUR 1268.4 |
Human IgG antibody Laboratories manufactures the iga antibody sars-2 reagents distributed by Genprice. The Iga Antibody Sars-2 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Antibody. Other Iga products are available in stock. Specificity: Iga Category: Antibody Group: Sars-2
SARS Antibody |
||
Affbiotech | 100ul | EUR 420 |
Human Herpes Simplex Virus 1 And 2 Antibody IgG (HSV1/2-IgG) ELISA Kit |
||
Abbexa | 96 tests | EUR 801.6 |
Anti-SARS-CoV-2 Antibody |
||
Biovision | 50 µg | EUR 576 |
SARS-CoV-2 Antibody (ORF3a) |
||
NSJ Bioreagents | 100 ug | EUR 390.15 |
Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-sense, single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). Virus particles include the RNA genetic material and structural proteins needed for invasion of host cells. Once inside the cell the infecting RNA is used to encode structural proteins that make up virus particles, nonstructural proteins that direct virus assembly, transcription, replication and host control and accessory proteins whose function has not been determined. ORF3a encodes a viral accessory protein. Based on its similarity to other coronavirus proteins, ORF3a protein is thought to be a protein with ion channel activity (viroporin) that activates the NLRP3 inflammasome. ORF3a may also play a role in virus replication and pathogenesis. |
SARS-CoV-2 Antibody (ORF8) |
||
NSJ Bioreagents | 100 ug | EUR 390.15 |
Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-sense, single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). Virus particles include the RNA genetic material and structural proteins needed for invasion of host cells. Once inside the cell the infecting RNA is used to encode structural proteins that make up virus particles, nonstructural proteins that direct virus assembly, transcription, replication and host control and accessory proteins whose function has not been determined.~ ORF8 encodes a viral accessory protein. |
SARS-CoV-2 Antibody (Nucleocapsid) |
||
NSJ Bioreagents | 100 ug | EUR 390.15 |
Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-sense, single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). Virus particles include the RNA genetic material and structural proteins needed for invasion of host cells. Once inside the cell the infecting RNA is used to encode structural proteins that make up virus particles, nonstructural proteins that direct virus assembly, transcription, replication and host control and accessory proteins whose function has not been determined. The structural proteins of SARS-CoV-2 include the envelope protein (E), spike or surface glycoprotein (S), membrane protein (M) and the nucleocapsid protein (N). The nucleocapsid phosphoprotein is a structural protein that binds to, protects the viral RNA genome and is involved in packaging the RNA into virus particles. The N protein has been suggested as an antiviral drug target. |
SARS-CoV-2 Antibody (NSP2) |
||
NSJ Bioreagents | 100 ug | EUR 390.15 |
Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-sense, single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). Virus particles include the RNA genetic material and structural proteins needed for invasion of host cells. Once inside the cell the infecting RNA is used to encode structural proteins that make up virus particles, nonstructural proteins that direct virus assembly, transcription, replication and host control and accessory proteins whose function has not been determined.~ ORF1ab, the largest gene, contains overlapping open reading frames that encode polyproteins PP1ab and PP1a. The polyproteins are cleaved to yield 16 nonstructural proteins, NSP1-16. Production of the longer (PP1ab) or shorter protein (PP1a) depends on a -1 ribosomal frameshifting event. The proteins, based on similarity to other coronaviruses, include the papain-like proteinase protein (NSP3), 3C-like proteinase (NSP5), RNA-dependent RNA polymerase (NSP12, RdRp), helicase (NSP13, HEL), endoRNAse (NSP15), 2'-O-Ribose-Methyltransferase (NSP16) and other nonstructural proteins. SARS-CoV-2 nonstructural proteins are responsible for viral transcription, replication, proteolytic processing, suppression of host immune responses and suppression of host gene expression. The RNA-dependent RNA polymerase is a target of antiviral therapies. |
SARS Spike Antibody |
|||
20-abx137184 | Abbexa |
|
|
SARS Spike Antibody |
|||
20-abx137200 | Abbexa |
|
|
SARS Spike Antibody |
|||
24216-100ul | SAB | 100ul | EUR 468 |
SARS Spike Antibody |
|||
24217-100ul | SAB | 100ul | EUR 468 |
SARS Spike Antibody |
|||
24218-100ul | SAB | 100ul | EUR 468 |
SARS Spike Antibody |
|||
24219-100ul | SAB | 100ul | EUR 468 |
SARS Spike Antibody |
|||
24318-100ul | SAB | 100ul | EUR 468 |
SARS Matrix Antibody |
|||
24319-100ul | SAB | 100ul | EUR 468 |
SARS Matrix Antibody |
|||
24320-100ul | SAB | 100ul | EUR 468 |
SARS Envelope Antibody |
|||
24321-100ul | SAB | 100ul | EUR 468 |
SARS Envelope Antibody |
|||
24322-100ul | SAB | 100ul | EUR 468 |
Anti-Nucleocapsid Antibody (SARS-CoV-2 ) |
|||
100861-1 | BPS Bioscience | 20 µg | EUR 285 |
Description: Recombinant human monoclonal antibody recognizing the SARS-CoV-2 Nucleocapsid (N) protein. |
Anti-Nucleocapsid Antibody (SARS-CoV-2 ) |
|||
100861-2 | BPS Bioscience | 100 µg | EUR 420 |
Description: Recombinant human monoclonal antibody recognizing the SARS-CoV-2 Nucleocapsid (N) protein. |
SARS-CoV-2 N Recombinant Antibody |
|||
A73671 | EpiGentek |
|
|
SARS-CoV-2 S Recombinant Antibody |
|||
A73672 | EpiGentek |
|
|
SARS-CoV-2 N Recombinant Antibody |
|||
A73676 | EpiGentek |
|
|
SARS-CoV-2 Antibody (NSP13 / Helicase) |
|||
RQ6307 | NSJ Bioreagents | 100 ug | EUR 390.15 |
Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-sense, single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). Virus particles include the RNA genetic material and structural proteins needed for invasion of host cells. Once inside the cell the infecting RNA is used to encode structural proteins that make up virus particles, nonstructural proteins that direct virus assembly, transcription, replication and host control and accessory proteins whose function has not been determined.~ ORF1ab, the largest gene, contains overlapping open reading frames that encode polyproteins PP1ab and PP1a. The polyproteins are cleaved to yield 16 nonstructural proteins, NSP1-16. Production of the longer (PP1ab) or shorter protein (PP1a) depends on a -1 ribosomal frameshifting event. The proteins, based on similarity to other coronaviruses, include the papain-like proteinase protein (NSP3), 3C-like proteinase (NSP5), RNA-dependent RNA polymerase (NSP12, RdRp), helicase (NSP13, HEL), endoRNAse (NSP15), 2'-O-Ribose-Methyltransferase (NSP16) and other nonstructural proteins. SARS-CoV-2 nonstructural proteins are responsible for viral transcription, replication, proteolytic processing, suppression of host immune responses and suppression of host gene expression. The RNA-dependent RNA polymerase is a target of antiviral therapies. |